These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease. Mirshahi A; Namavari A; Djalilian A; Moharamzad Y; Chams H Ocul Immunol Inflamm; 2009; 17(1):59-64. PubMed ID: 19294576 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Rabena MD; Pieramici DJ; Castellarin AA; Nasir MA; Avery RL Retina; 2007; 27(4):419-25. PubMed ID: 17420692 [TBL] [Abstract][Full Text] [Related]
12. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema. Kim M; Lee P; Kim Y; Yu SY; Kwak HW Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for treatment of uveitic macular edema. Cordero Coma M; Sobrin L; Onal S; Christen W; Foster CS Ophthalmology; 2007 Aug; 114(8):1574-1579.e1. PubMed ID: 17363060 [TBL] [Abstract][Full Text] [Related]
14. Treatment of macular edema because of occlusive vasculitis with bevacizumab (avastin): efficacy of three consecutive monthly injections. Nuti E; Traversi C; Marigliani D; Balestrazzi A; Alegente M; Martone G; Malandrini A; Romeo N; Mazzotta C; Tosi GM Retina; 2011 Oct; 31(9):1863-70. PubMed ID: 21799465 [TBL] [Abstract][Full Text] [Related]